Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis
Jeffrey H. Lin(University of Pennsylvania), Robert H. Vonderheide(Parker Institute for Cancer Immunotherapy)
Cited by 175
Related Papers
Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
|Cancer Immunology Research|2015|467
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer
|Clinical Cancer Research|2021|178
Tumor cell–intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2)
|Journal of Clinical Investigation|2019|167
CCL5 mediates CD40-driven CD4+ T cell tumor infiltration and immunity
|JCI Insight|2020|130